VIVANI MEDICAL INC.

Vivani Medical Provides Business Update Including $3M Equity Financing and Reports First Quarter 2025 Financial Results

13 5 2025 16:30:00 提供 Nasdaq GlobeNewswire

Vivani Medical to Present at the American Association of Pharmaceutical Scientists’ “Beyond GLP1s: Where the Science will Take Business Next” Virtual Workshop

07 5 2025 08:30:00 提供 Nasdaq GlobeNewswire

Vivani Medical to Participate in Virtual Fireside Chat Hosted by H.C. Wainwright & Company

16 4 2025 08:30:00 提供 Nasdaq GlobeNewswire

Vivani Medical and Okava Expand Collaboration to Develop OKV-119 for Dogs, Targeting Metabolic Health and Longevity

15 4 2025 08:30:00 提供 Nasdaq GlobeNewswire

Vivani Medical Provides Business Update and Reports Fourth Quarter and Full Year 2024 Financial Results

31 3 2025 07:30:00 提供 Nasdaq GlobeNewswire

Vivani Medical Announces $8.25M Private Placement Equity Financing

27 3 2025 07:32:56 提供 Nasdaq GlobeNewswire

Vivani Medical Announces Positive Preclinical Weight Loss Data for NPM-139 Semaglutide Implant, with Potential for Once-Yearly Dosing

26 3 2025 07:30:00 提供 Nasdaq GlobeNewswire